Neurogenetic interactions and aberrant behavioral co-morbidity of attention deficit hyperactivity disorder (ADHD): Dispelling myths

Theoretical Biology and Medical Modelling

Volumn 2, Issue , 2005, Pages

  Comings, David E ^a   Chen, Thomas J H ^b   Blum, Kenneth ^c,d   Mengucci, Julie F ^e   Blum, Seth H ^e   Meshkin, Brian ^d  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d Salugen Inc   (United States)

^e Synapatmine Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ATOMOXETINE; ATYPICAL ANTIPSYCHOTIC AGENT; CENTRAL STIMULANT AGENT; CLONIDINE; DEXAMPHETAMINE; ENZYME; GUANFACINE; HERBACEOUS AGENT; METHYLPHENIDATE; MOLINDONE; NEUROTRANSMITTER; NEUROTRANSMITTER RECEPTOR; NUTRACEUTICAL; OLANZAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; VACCINE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR DISORDER; BEHAVIOR MODIFICATION; BIOFEEDBACK THERAPY; CLINICAL TRIAL; COMORBIDITY; CONDUCT DISORDER; DISEASE EXACERBATION; DISEASE SEVERITY; DNA POLYMORPHISM; DRUG DEPENDENCE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; ELECTROENCEPHALOGRAM; FAMILY THERAPY; GENETIC DISORDER; GENETICS; HEAVY METAL POISONING; HUMAN; METABOLISM; NONHUMAN; OPPOSITIONAL DEFIANT DISORDER; PARIETAL LOBE; PATHOLOGICAL GAMBLING; PREFRONTAL CORTEX; PREVALENCE; REVIEW; SUBSTANCE ABUSE; THERAPY; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; GENETIC PREDISPOSITION; MULTIFACTORIAL INHERITANCE; PATHOPHYSIOLOGY; PSYCHOLOGY;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MULTIFACTORIAL INHERITANCE; NEUROTRANSMITTER AGENTS;

EID: 31544477166     PISSN: 17424682     EISSN: 17424682     Source Type: Journal    
DOI: 10.1186/1742-4682-2-50     Document Type: Review

References (83)

1. American Psychiatric Association: Diagnostic and Statistical Manual of the American Psychiatric Assn. IV-TR™ Washington, D.C.: American Psychiatric Association; 2000.
2. Neuman RJ, Sitdhiraksa N, Reich W, Ji TH, Joyner CA, Sun LW, Todd RD: Estimation of prevalence of DSM-IV and latent classdefined ADHD subtypes in a population-based sample of child and adolescent twins. Twin Res Hum Genet 2005, 8:392-401.
3. Wolraich ML, Hannah JN, Baumgaertel A, Feurer ID: Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a county-wide sample. J Dev Behav Pediatr 1998, 19:162-168.
4. Biederman J, Mick E, Faraone SV: Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact or remission definition and symptoms type. Am Psychiatry 2000, 157:816-818.
5. Centers for Disease Control and Prevention (CDC): Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder - United States, 2003. MMWR Morb Mortal Wkly Rep 2005, 54:842-847.
6. Sherman DK, McGue MK, Iacono WG: Twin concordance for attention deficit hyperactivity disorder: a comparison of teachers' and mothers' reports. Am J Psychiatry 1997, 154:532-535.
7. Hudziak JJ, Derks EM, Althoff RR, Rettew DC, Boomsma DI: The genetic and environmental contributions to attention deficit hyperactivity disorder as measured by the conners' rating scales - revised. Am J Psychiatry 2005, 162:1614-1620.
8. Kuntsi J, Rijsdijk F, Ronald A, Asherson P, Plomin R: Genetic influences on the stability of attention-deficit/hyperactivity disorder symptoms from early to middle childhood. Biol Psychiatry 2005, 57:647-654.
9. Cadoret RJ, Stewart MA: An adoption study of attention deficit/hyperactivity/aggression and their relationship to adult antisocial personality. Compr Psychiatry 1991, 32:73-82.
10. Cunningham L, Cadoret RJ, Loftus R, Edwards J: Studies of adoptees from psychiatrically disturbed biological parents. I. Psychiatric conditions in childhood and adolescence. Br J Psychiatry 1995, 126:534-549.
11. Cantwell DP: Genetic studies of hyperactive children: Psychiatric illness in biologic and adopting parents. In Genetic Research in Psychiatry Edited by: Rosenthal D, Brill H. Baltimore, MD: Johns Hopkins Press; 1975:259-272.
12. Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA: Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 1993, 262:578-580.
13. Comings DE: Polygenic inheritance of psychiatric disorders. In Handbook of Psychiatric Genetics Edited by: Blum K. Boca Raton, FL: CRC Press; 1996:235-260.
14. Pritchard JK: Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 2001, 69(1):124-137.
15. Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Blake H, Dietz G, Saucier G, MacMurray JP: Comparison of the role of dopamine, serotonin, and noradrenaline genes in ADHD, ODD and conduct disorder: multivariate regression analysis of 20 genes. Clin Genet 2000, 57:178-196.
16. Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Blake H, Chiu F, Wang E, Farwell K, Darakjy S, Baker R, Dietz G, Saucier G, MacMurray JP: Multivariate analysis of associations of 42 genes in ADHD, ODD and conduct disorder. Clin Genet 2000, 58:31-40.
17. Comings DE: The Real Problem with Association Studies. Am J Med Genet (Neuropsychiatric Genetics) 2003, 116(1 suppl):102.
18. Miller D, Blum K: Overload. Attention Deficit Disorder and the Addictive Brain Duarte, CA: Hope Press; 2000.
19. Hafting T, Fyhn M, Molden S, Moser M, Moser El: Microstructure of a spatial map in the entorhinal cortex. Nature 2005, 436:801-806.
20. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M: Adult psychiatric status of hyperactive boys grown up. Am J Psychiatry 1998, 155:493-498.
21. Hechtman L, Weiss G: Controlled prospective fifteen-year follow-up of hyperactives as adults. Non-medical drug and alcohol use and anti-social behavior. Can J Psychiatry 1986, 31:557-567.
22. Howell DC, Huessy HR: Hyperkinetic behavior followed from 7 to 21 years of age. In Strategic Interventions for Hyperactive Children Gittelman M. Sharpe: Armonk, NY; 1981:201-215.
23. Klein R, Mannuzza S: Long-term outcome of hyperactive children: A review. J Am Acad Child Adolesc Psychiatry 1991, 30:383-387.
24. Olweus D: Stability of aggressive reaction patterns in males: A review. Psychological Bull 1979, 86:852-875.
25. Robins LN: Deviant Children Grown Up Baltimore: Williams & Wilkins; 1966.
26. Farrington DP, Loeber R, Elliott DS, Hawkins JD, Kandel DB: Advancing knowledge abut the onset of delinquency and crime. Adv Clin Child Psychology 1990, 13:283-342.
27. McCord J: Some child-rearing antecedents of criminal behavior in adult men. J Pers Soc Psychol 1979, 9:1477-1486.
28. Graham P, Rutter M: Psychiatric disorders in the young adolescent: A follow-up study. Proc Roy Soc Med 1973, 66:1226-1229.
29. Eyestone L, Howell RJ: An epidemiological study of attention-deficit disorder and major depression in a male prison population. Bull Am Acad Psychiatry Law 1994, 22:181-193.
30. McCallon D: Personal communication.
31. Biederman J, et al.: High rate of affective disorders in probands with attention deficitdisorder and their relatives: A controlled family study. Am J Psychiatry 1987, 144:330-333.
32. Barkley RA, Fischer M, Edelbrock CS, Smallish L: The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1990, 29:546-557.
33. Spencer TJ, Biederman J, Wilens TE, Faraone SV: Overview and neurobiology of attention-deficit/hyperactivity disorder. J Clin Psychiatry 2002, 63(Suppl 12):3-9.
34. Castellanos FX: Toward a pathophysiology of attention-deficit/ hyperactivity disorder. Clin Pediatr (Phila) 1997, 36(7):381-393.
35. Barkley RA: Attention-deficit/hyperactivity disorder, self-regulation, and time: toward a more comprehensive theory. J Dev Behav Pediatr 1997, 18(4):271-279.
36. Damasio AR: Descartes' Error New York: G.P. Putnam's Sons; 1994.
37. Posner MI, Peterson SE: The attention system of the human brain. Annu Rev Neurosci 1990, 13:25-42.
38. Halperin JM, Newcorn JH, Koda VH, Pick L, McKay KE, Knott P: Noradrenergic mechanisms in ADHD children with and without reading disabilities: A replication and extension. J Am Acad Child Adolesc Psychiatry 1997, 36:1688-1696.
39. Aston-Jones G, Cohen D: An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu Rev Neurosci 2005, 28:403-450.
40. Goodwin DW, Schulsinger F, Hermansen L, Guze SB, Winokur G: Alcoholism and the hyperactive child syndrome. J Nerv Ment Dis 1975, 160:349-353.
41. Loney J, Kramer J, Milich R: The hyperkinetic child grows up: Predictors of symptoms, delinquency, and achievement at follow-up. In Psychosocial Aspects of Drug Treatment for Hyperactivity Edited by: Gadow K, Loney J. Bolder, Colorado: Westview Press; 1981:381-415.
42. Wilens TE, Biederman J, Mick E, Faraone SV, Spencer T: Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorder. J Nerv Ment Dis 1997, 185:475-482.
43. Wood DR, Wender PH, Reimherr FE: The prevalence of attention deficit disorder, residual type, or minimal brain dysfunction, in a population of male alcoholic patients. Am J Psychiatry 1983, 140:95-98.
44. Horner RB, Scheibe KE: Prevalence and implication of attention-deficit hyperactivity disorder among adolescents in treatment for substance abuse. J Amer Acad Child Adolesc Psychiat 1997, 36:30-36.
45. Blum K, Cull JG, Braverman ER, Comings DE: Reward Deficiency Syndrome. American Scientist 1996, 84:132-145.
46. Lee H-J, Lee H-S, Kim Y-K, Kim L, Lee MS, Jung I-K, Suh K-Y, Kim S: D2 and D4 dopamine Receptor Gene Polymorphisms and Personality Traits in a young Korean Population. American J Med Gen 2003, 121:44-49.
47. Noble EP, Ozkaragoz TZ, Ritchie T, Zhang X, Belin TR, Sparkes RS: D2 and D4 dopamine receptor polymorphisms and personality. American J Med Gen 1998, 81:257-267.
48. Koepp MJ, Gunn RN, Lawrence AD, Cunningham VJ, Dagher A, Jones T, Brooks DJ, Bench CJ, Grasby PM: Evidence for striatal dopamine release during a video game. Nature 1998, 393:266-268.
49. Comings DE, Rosenthal RJ, Lesieur HR, Rugle L, Muhleman D, Chiu C, Dietz G, Gade R: A study of the dopamine D2 receptor genin pathological gambling. Pharmacogenetics 1996, 6:223-234.
50. Rodriguez-Jimenez R, Avila C, Ponce G, Ibanez MI, Jimenez M, Monasor R, Jurado R, Jimenez-Arriero MA, Rubio G, Palomo T: Neuropsychology of pathological gamblers: influence of attention-deficit/ hyperactivity disorder in childhood. In International meeting on implications of comorbidity for etiology and treatment of neuropsychiatric disorders Mazagon (Huelva) Spain; 2005:28.
51. Biederman J, Wilens T, Mick E, Spencer T, Faraone SV: Pharmacology of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics 1999, 104:1-5.
52. Blum K, Chen JTH, Blum S, Downs WB, Braverman Mengucci J, Meshkin B: Nutrigenomics & pharmacogenomics: A scientific wonderland. Biology Of Social Life in press.
53. Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ: Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 1999, 354:2132-2133.
54. Dresel S, Krause J, Krause KH, LaFougere C, Brinkbaumer K, Kung HF, Hahn K, Tatsch K: Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Eur J Nucl Med 2000, 27(10):1518-1524.
55. Giros BSR, Wightman RM, Caron MG: Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking dopamine transporter. Nature 1996, 379:606-612.
56. Winsberg B, Comings D: Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. J Am Acad Child Adolesc Psychiatry 1999, 38:1474-1477.
57. Kirley A, Lowe N, Hawi Z, Mullins C, Daly G, Waldman I, McCarron M, O'Donnell D, Fitzgerald M, Gill M: Association of the 480 bp DAT1 Allele With Methyphenidate Response in a Sample of Irish Children With ADHD. Am J Med Gen 2003, 121B:50-54.
58. 2 receptor gene in alcoholism. JAMA 1990, 263:2055-2060.
59. Blum K, Noble EP, Sheridan PJ, Finley O, Montgomery A, Ritchie T, Ozkaragoz T, Fitch RJ, Sadlack F, Sheffield D: Association of the A1 allele of the D2 dopamine receptor gene with severe alcoholism. Alcohol 1991, 8:409-416.
60. O'Hara BF, Smith SS, Bird G, Persico AM, Suarez BK, Cutting GR, Uhl GR: Dopamine D2 receptor RFLPs, haplotypes and their association with substance use in black and Caucasian research volunteers. Hum Hered 1993, 43(4):209-218.
61. Goldman D, Brown GL, Albaugh B, Robin R, Goodson S, Trunzo M, Akhtar L, Lucas-Derse S, Long J, Linnoila M: DRD2 dopamine receptor genotype, linkage diseqilibrium and alcoholism in American Indians and other populations. Alcohol Clin Exp Res 1993, 17:199-204.
62. 4 dopamine receptor alleles in chronic alcoholism. Biochem Biophys Res Commun 1993, 196:107-114.
63. Neville MJ, Johnstone EC, Walton RT: Identification and Characterization of ANKK1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Human Mutation 2004, 23:540-545.
64. Comings DE: The clinical and molecular genetics of ADHD and Tourette syndrome: Two related polygenic disorders. In Adult Attention Deficit Disorder: Brain Mechanisms and Life Outcomes Volume 931. Edited by: Wasserstein J, Wolf L, LeFevre FF. New York: Annals NY Acad Sci; 2001:50-83.
65. Chen TJH, Blum K, Mathews D, Fisher L, Schnautz N, Braverman ER, Schoolfield J, Downs BW, Comings DE: Are dopaminergic genes involved in a predisposition to pathological aggression? Hypothesizing the importance of "super controls" in psychiatricgenetic research of complex behavioral disorders. Medical Hypotheses 2005, 65:703-707.
66. Comings DE: Treatment of Tourette Syndrome,. In Coon's Current Therapy 2003 Edited by: Rakel RE, Bope ET. New York: Elsiver Science (USA); 2003:983-987.
67. Gadow KD, Nolan EE, Sverd J: Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school setting. J Am Acad Child Adolesc Psychiatry 1992, 31:462-471.
68. Geyer MA: The family of sensorimotor gating disorders: Comorbidities or diagnostic overlaps? In International meeting on implications of comorbidity for etiology and treatment of neuropsychiatric disorders Mazagon (Huelva) Spain; 2005:S5. A4.
69. The MTA Cooperative Group: Multimodal Treatment Study of Children with ADHD. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999, 56(12):1073-1086.
70. Lubar JF, Swartwood MO, Swartwood JN, O'Donnell PH: Evaluation of the effectiveness of EEG neurofeedback training for ADGD in a clinical setting by changes in T.O.V.A. scores., behavioral ratings and WISC-R performance. Biofeedback and Self Regulation 1995, 20:83-99.
71. Brown R, Gerbarg Pl, Ramazanov Z: Rhodiola rosea: A phytomedicinal overview. J Amer Botanical Council 2002, 56:40-52.
72. Defrance JF, Hymel C, Trachtenberg MC, Ginsberg LD, Schweitzer FC, Estes S, Chen TJH, Braverman ER, Cull JG, Blum K: Enhancement of attention processing by Kantroll in healthy humans. A pilot study. Clin Electroenceph 1997, 28:68-75.
73. Wood DR, Reimer FW, Wender PH: Treatment of Attention deficit Disorder with DL-phenylalanine. Psychiatry Research 1985, 16:21.
74. Chen TJH, Blum K, Payte JT, Schoolfield J, Hopper D, Stanford M, Braverman ER: Narcotic antagonists in drug dependence: pilot study showing enhancement of compliance with SYN-10, amino-acid precursors and enkephalinase inhibition therapy. Medical Hypotheses 2004, 63:538-548.
75. Kirby D: Evidence of Harm New York: St. Martin's Press; 2005.
76. Stehr-Green T, Tull P, Stellfeld M, Mortenson PB, Simpson D: Autism and Thimerosal-Containing Vaccines. Lack of Consistent Evidence for an Association. Amer J Preventive Med 2003, 25:101-106.
77. Faraone S: Report from the 4th International Meeting of the Attention Deficit Hyperactivity Disorder Molecular Genetics Network. American J Med Gen 2003, 121:55-59.
78. Laurin N, Misener VL, Crosbie J, Ickowicz A, Pathare T, Roberts W, Malone M, Tannock R, Schachar R, Kennedy JL, Barr CL: Association of the calcyon gene (DRD1IP) with attention deficit/hyperactivity disorder. Mol Psychiatry in press. 2005 Sep 20
79. Paclt I, Koudelova J, Krepelova A, Uhlikova P, Gazdikova M, Bauer P: Biochemical markers and genetic research of ADHD. Review. Neuro Endocrinol Lett in press. 2005 Aug 30
80. Walitza S, Renner TJ, Dempfle A, Konrad K, Wewetzer C, Halbach A, Herpertz-Dahlmann B, Remschmidt H, Smidt J, Linder M, Flierl L, Knolker U, Friedel S, Schafer H, Gross C, Hebebrand J, Warnke A, Lesch KP: Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder. Mol Psychiatry in press. 2005 Aug 23
81. Comings DE, Blum K: Reward Deficiency Syndrome: Genetic Aspects Of Behavioral Disorders and Validation. In International meeting on implications of comorbidity for etiology and treatment of neuropsychiatric disorders Mazagon (Huelva) Spain; 2005. (to be published in Neurotoxcicity)
82. Seeman P, Madras BK: Anti-hyperactivity medication: methylphenidate and amphetamine. Molecular Psychiatry 1998, 3:386-396.
83. Biederman J, Faraone SV, Spencer T, Wilens T, Norman D, Lapey KA, Mick E, Lehman BK, Doyle A: Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1993, 150:1792-1798.